Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma.

Joshi BH, Puri RA, Leland P, Varricchio F, Gupta G, Kocak M, Gilbertson RJ, Puri RK; US Pediatric Brain Tumor Consortium.

Neuro Oncol. 2008 Jun;10(3):265-74. doi: 10.1215/15228517-2007-066. Epub 2008 Apr 22.

2.

Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas.

Okada H, Low KL, Kohanbash G, McDonald HA, Hamilton RL, Pollack IF.

J Neurooncol. 2008 Jul;88(3):245-50. doi: 10.1007/s11060-008-9566-9. Epub 2008 Mar 7.

3.

Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.

Kawakami M, Kawakami K, Takahashi S, Abe M, Puri RK.

Cancer. 2004 Sep 1;101(5):1036-42.

4.

Identification of a human leukocyte antigen-A24-restricted T-cell epitope derived from interleukin-13 receptor alpha2 chain, a glioma-associated antigen.

Shimato S, Natsume A, Wakabayashi T, Tsujimura K, Nakahara N, Ishii J, Ito M, Akatsuka Y, Kuzushima K, Yoshida J.

J Neurosurg. 2008 Jul;109(1):117-22. doi: 10.3171/JNS/2008/109/7/0117.

PMID:
18590440
5.

ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma.

Gilbertson RJ, Hill DA, Hernan R, Kocak M, Geyer R, Olson J, Gajjar A, Rush L, Hamilton RL, Finkelstein SD, Pollack IF.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3620-4.

6.

IL-13 receptor α2 stimulates human glioma cell growth and metastasis through the Src/PI3K/Akt/mTOR signaling pathway.

Tu M, Wange W, Cai L, Zhu P, Gao Z, Zheng W.

Tumour Biol. 2016 Nov;37(11):14701-14709. Epub 2016 Sep 14.

PMID:
27623944
7.
8.

Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.

Kioi M, Kawakami M, Shimamura T, Husain SR, Puri RK.

Cancer. 2006 Sep 15;107(6):1407-18.

10.

Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker.

Kawakami M, Kawakami K, Kasperbauer JL, Hinkley LL, Tsukuda M, Strome SE, Puri RK.

Clin Cancer Res. 2003 Dec 15;9(17):6381-8.

11.

Interleukin 13 mediates signal transduction through interleukin 13 receptor alpha2 in pancreatic ductal adenocarcinoma: role of IL-13 Pseudomonas exotoxin in pancreatic cancer therapy.

Shimamura T, Fujisawa T, Husain SR, Joshi B, Puri RK.

Clin Cancer Res. 2010 Jan 15;16(2):577-86. doi: 10.1158/1078-0432.CCR-09-2015. Epub 2010 Jan 12.

12.

[Preliminary study on aberrant expression of miRNAs related to the formation of the distinction between pediatric and adult types of brainstem gliomas].

Wang X, Zhang HW, Zhang AL, Han L, Wang K, Pu PY, Shen CH, Kang CS, Yu CJ.

Zhonghua Wai Ke Za Zhi. 2012 Nov;50(11):1015-20. Chinese.

PMID:
23302488
13.

A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.

Fujisawa T, Joshi B, Nakajima A, Puri RK.

Cancer Res. 2009 Nov 15;69(22):8678-85. doi: 10.1158/0008-5472.CAN-09-2100. Epub 2009 Nov 3.

14.

Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas.

Pollack IF, Jakacki RI, Butterfield LH, Hamilton RL, Panigrahy A, Potter DM, Connelly AK, Dibridge SA, Whiteside TL, Okada H.

J Clin Oncol. 2014 Jul 1;32(19):2050-8. doi: 10.1200/JCO.2013.54.0526. Epub 2014 Jun 2.

15.

Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes.

Saratsis AM, Kambhampati M, Snyder K, Yadavilli S, Devaney JM, Harmon B, Hall J, Raabe EH, An P, Weingart M, Rood BR, Magge SN, MacDonald TJ, Packer RJ, Nazarian J.

Acta Neuropathol. 2014;127(6):881-95. doi: 10.1007/s00401-013-1218-2. Epub 2013 Dec 3.

16.

Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy.

Lai EW, Joshi BH, Martiniova L, Dogra R, Fujisawa T, Leland P, de Krijger RR, Lubensky IA, Elkahloun AG, Morris JC, Puri RK, Pacak K.

J Clin Endocrinol Metab. 2009 Aug;94(8):2952-7. doi: 10.1210/jc.2009-0309. Epub 2009 Jun 2.

17.

Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells.

Zhao Y, He D, Zhao J, Wang L, Leff AR, Spannhake EW, Georas S, Natarajan V.

J Biol Chem. 2007 Apr 6;282(14):10172-9. Epub 2007 Feb 6.

18.

IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13.

Mintz A, Gibo DM, Slagle-Webb B, Christensen ND, Debinski W.

Neoplasia. 2002 Sep-Oct;4(5):388-99.

19.

Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy.

Yeung JT, Hamilton RL, Okada H, Jakacki RI, Pollack IF.

J Neurooncol. 2013 Jan;111(2):103-11. doi: 10.1007/s11060-012-0998-x. Epub 2012 Nov 21.

20.

Expression of IL-13Ralpha2 in liver cancer cells and its effect on targeted therapy of liver cancer.

Hou L, Du J, Wang J, Liu Y, Sun W, Zheng Y, Zhang L, Hu H, Dai X, Guan W, Ma Y, Hong T.

J Cancer Res Clin Oncol. 2010 Jun;136(6):839-46. doi: 10.1007/s00432-009-0724-z. Epub 2009 Nov 15.

PMID:
19916021

Supplemental Content

Support Center